DE69621837T2 - Methoden zur feststellung von alzheimerscher krankheit - Google Patents

Methoden zur feststellung von alzheimerscher krankheit

Info

Publication number
DE69621837T2
DE69621837T2 DE69621837T DE69621837T DE69621837T2 DE 69621837 T2 DE69621837 T2 DE 69621837T2 DE 69621837 T DE69621837 T DE 69621837T DE 69621837 T DE69621837 T DE 69621837T DE 69621837 T2 DE69621837 T2 DE 69621837T2
Authority
DE
Germany
Prior art keywords
disease
methods
alzheimersch
detecting
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69621837T
Other languages
English (en)
Other versions
DE69621837D1 (de
Inventor
M Kay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of DE69621837D1 publication Critical patent/DE69621837D1/de
Application granted granted Critical
Publication of DE69621837T2 publication Critical patent/DE69621837T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69621837T 1996-01-19 1996-12-13 Methoden zur feststellung von alzheimerscher krankheit Expired - Fee Related DE69621837T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1025096P 1996-01-19 1996-01-19
PCT/US1996/020465 WO1997026537A1 (en) 1996-01-19 1996-12-13 Methods for the detection of alzheimer's disease

Publications (2)

Publication Number Publication Date
DE69621837D1 DE69621837D1 (de) 2002-07-18
DE69621837T2 true DE69621837T2 (de) 2002-11-28

Family

ID=21744819

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621837T Expired - Fee Related DE69621837T2 (de) 1996-01-19 1996-12-13 Methoden zur feststellung von alzheimerscher krankheit

Country Status (7)

Country Link
EP (1) EP0877939B1 (de)
JP (1) JP2000503391A (de)
AT (1) ATE219247T1 (de)
CA (1) CA2242343A1 (de)
DE (1) DE69621837T2 (de)
ES (1) ES2176523T3 (de)
WO (1) WO1997026537A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301730A (zh) * 1999-12-24 2001-07-04 上海博德基因开发有限公司 一种新的多肽——阴离子交换蛋白9和编码这种多肽的多核苷酸
CN1301720A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——阴离子交换蛋白9和编码这种多肽的多核苷酸
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
KR20080090408A (ko) 2005-11-30 2008-10-08 아보트 러보러터리즈 항-Ａβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법
DK1976877T4 (en) 2005-11-30 2017-01-16 Abbvie Inc Monoclonal antibodies to amyloid beta protein and uses thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
JP2013523182A (ja) 2010-04-15 2013-06-17 アボット・ラボラトリーズ アミロイドベータ結合タンパク質
CN105348387B (zh) 2010-08-14 2020-08-25 Abbvie 公司 β淀粉样蛋白结合蛋白
US9588129B2 (en) * 2013-03-15 2017-03-07 Amira Medical Technologies Inc. Methods for analyzing blood to detect diseases associated with abnormal protein aggregation

Also Published As

Publication number Publication date
EP0877939A1 (de) 1998-11-18
WO1997026537A1 (en) 1997-07-24
ES2176523T3 (es) 2002-12-01
DE69621837D1 (de) 2002-07-18
CA2242343A1 (en) 1997-07-24
JP2000503391A (ja) 2000-03-21
EP0877939B1 (de) 2002-06-12
ATE219247T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
DE59000200D1 (de) Verfahren zur gewinnung von erdgas.
DE69612017D1 (de) Emulsion zur robusten erfassung von gasen
DE69114869D1 (de) Verfahren zur Bestimmung des Profils von Reifen.
AU698862B2 (en) A screening method for identifying ligands for target proteins
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
SE9604815D0 (sv) A metod of diagnosis
ATE342510T1 (de) Komplementierungsassay für den nachweis von protein-löslichkeit und -faltung
DE69535901D1 (de) Proteinkinase npk-110
DE69021729D1 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
DE69717001D1 (de) Verfahren zur Bestimmung des Endpunktes von enzymatischen Nachweisverfahren
DE69534077D1 (de) Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden
DE69018840D1 (de) Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes.
DE69924617D1 (de) Immunologische Bestimmung des hydrophoben Lungensurfaktantproteins SP-C
ATE147861T1 (de) Funktioneller test zur bestimmung der protein s- aktivität
NZ333075A (en) isolated protein markers for use in diagnosing esophageal cancer
ATE347613T1 (de) Verfahren zur bestimmung von alkalischer phosphatase unter beseitigung von hämoglobin- störungen
DE59708783D1 (de) Diagnosehilfe sowie verfahren zum nachweis der trächtigkeit von wiederkäuern
DE69533200D1 (de) Verfahren zur prüfung von immunokompetenz
ATE323288T1 (de) Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.
DE69832622D1 (de) Methoden zur durchforstung (screenen) von proteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee